WT1 and astrocytoma (excluding glioblastoma): The reverse also seems true, as IHC analysis of FFPE tumor sections from astrocytoma animal models transduced with anti-WT1 shRNA revealed that the Ki67 proliferation index was higher in the control tumors (Kijima et al., 2016).